Biotech entrepreneur investing in a ‘new generation’ of cancer, chronic disease treatments

Graviton Chairman and co-CEO Sam Waksal details how a new drug can meet an unmet medical need treating diseases like cancer, ALS, Alzheimer’s, schizophrenia and Parkinson’s.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.